Close

What are ADC's

Our services

ADC Review
is made possible by:




ADC 101

All you need to know about Antibody-Drug-Conjugates just a click away...

The Next Generation Pharmaceuticals

What Are Antibody-Drug Conjugates?

How do ADCs work

Monoclonal Antibodies

Stable Linker (Technologies)

Cytotoxic Agents

Targeting Cancer with Antibody-drug Conjugates

Immunoglobulin G (IgG) antibody isotypes

Antibody Dependent Cell-Mediated Cytotoxicity

Changing Strategies in the War on Cancer – 1

Changing Strategies in the War on Cancer – 2

Changing Strategies in the War on Cancer – 3

Characterization of Antibody-drug Conjugates

Can an ADC be Greater than the Sum of Its Parts?

Package Inserts -Antibody-drug Conjugates

ADC Drug Map

Recommended Reading

Clinical Trials

Share

Recommended Articles

Four Ways to Show Nonobviousness of ADC Inventions

05 October, 2018

When the first antibody-drug conjugate (ADC) was approved by the U.S. Food and Drug Administration (FDA) in 2000,[1] only a handful of patent applications claiming ADCs had been published.[2] As research cont...


Skip to toolbar